These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Patient preferences for treating refractory overactive bladder in the UK. Hashim H; Beusterien K; Bridges JF; Amos K; Cardozo L Int Urol Nephrol; 2015 Oct; 47(10):1619-27. PubMed ID: 26347077 [TBL] [Abstract][Full Text] [Related]
8. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device. Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700 [TBL] [Abstract][Full Text] [Related]
9. Electrical and mechanical office-based neuromodulation. Kacker R; Lay A; Das A Urol Clin North Am; 2013 Nov; 40(4):581-9. PubMed ID: 24182977 [TBL] [Abstract][Full Text] [Related]
10. Sacral nerve stimulation for urinary dysfunction: the first year of the Scottish national service. Hilmy M; Tatarov O; McQueen L; Small D; Granitsiotis P; Conn IG Scott Med J; 2012 Nov; 57(4):200-3. PubMed ID: 23138579 [TBL] [Abstract][Full Text] [Related]
11. Sacral nerve stimulation for the overactive bladder. Leng WW; Morrisroe SN Urol Clin North Am; 2006 Nov; 33(4):491-501, ix. PubMed ID: 17011385 [TBL] [Abstract][Full Text] [Related]
12. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study. Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979 [TBL] [Abstract][Full Text] [Related]
13. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children. Barroso U; Viterbo W; Bittencourt J; Farias T; LordĂȘlo P J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257 [TBL] [Abstract][Full Text] [Related]
14. Do Patients Discontinue Overactive Bladder Medications after Sacral Neuromodulation? Amin K; Moskowitz D; Kobashi KC; Lee UJ; Lucioni A J Urol; 2019 May; 201(5):973-978. PubMed ID: 30694936 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541 [TBL] [Abstract][Full Text] [Related]
16. Urethral instability and sacral nerve stimulation-a better parameter to predict efficacy? Groenendijk PM; Heesakkers JP; Lycklama A Nijeholt AA J Urol; 2007 Aug; 178(2):568-72; discussion 572. PubMed ID: 17570438 [TBL] [Abstract][Full Text] [Related]
17. First-in-human implantation of a mid-field powered neurostimulator at the sacral nerve: Results from an acute study. van Kerrebroeck PEVA; Reekmans M; van Koeveringe GA; Yeh AJ; Fayram TA; Sharan AD; Comiter CV Neurourol Urodyn; 2019 Aug; 38(6):1669-1675. PubMed ID: 31107559 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of sacral nerve stimulation for fecal incontinence. George AT; Kalmar K; Panarese A; Dudding TC; Nicholls RJ; Vaizey CJ Dis Colon Rectum; 2012 Mar; 55(3):302-6. PubMed ID: 22469797 [TBL] [Abstract][Full Text] [Related]